NO902336D0 - Antispasmotiske midler. - Google Patents

Antispasmotiske midler.

Info

Publication number
NO902336D0
NO902336D0 NO902336A NO902336A NO902336D0 NO 902336 D0 NO902336 D0 NO 902336D0 NO 902336 A NO902336 A NO 902336A NO 902336 A NO902336 A NO 902336A NO 902336 D0 NO902336 D0 NO 902336D0
Authority
NO
Norway
Prior art keywords
antispasmotic
agents
compounds
gut
proviso
Prior art date
Application number
NO902336A
Other languages
English (en)
Other versions
NO902336L (no
Inventor
David Alker
Peter Edward Cross
Robert John Bass
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO902336D0 publication Critical patent/NO902336D0/no
Publication of NO902336L publication Critical patent/NO902336L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
NO90902336A 1989-05-27 1990-05-25 Antispasmotiske midler. NO902336L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898912303A GB8912303D0 (en) 1989-05-27 1989-05-27 Therapeutic agents

Publications (2)

Publication Number Publication Date
NO902336D0 true NO902336D0 (no) 1990-05-25
NO902336L NO902336L (no) 1990-11-28

Family

ID=10657526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902336A NO902336L (no) 1989-05-27 1990-05-25 Antispasmotiske midler.

Country Status (20)

Country Link
US (1) US5071844A (no)
EP (1) EP0404359B1 (no)
JP (1) JPH0317079A (no)
KR (1) KR900018091A (no)
CN (1) CN1047673A (no)
AT (1) ATE107927T1 (no)
AU (1) AU5595490A (no)
CA (1) CA2017535C (no)
DD (1) DD294718A5 (no)
DE (1) DE69010285T2 (no)
DK (1) DK0404359T3 (no)
ES (1) ES2055867T3 (no)
FI (1) FI96950C (no)
GB (1) GB8912303D0 (no)
HU (1) HUT58329A (no)
IE (1) IE64196B1 (no)
IL (1) IL94457A0 (no)
NO (1) NO902336L (no)
PL (1) PL285350A1 (no)
PT (1) PT94151B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94295A0 (en) * 1989-05-25 1991-03-10 Fujisawa Pharmaceutical Co Thiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IT1247509B (it) * 1991-04-19 1994-12-17 Univ Cagliari Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
TW479057B (en) * 1996-03-11 2002-03-11 Ajinomoto Kk 5,11-dihydrobenzo[b,e] [1,4]oxazepine derivatives and pharmaceutical composition containing the same
DE69811520T2 (de) * 1997-09-10 2003-12-11 Ajinomoto Kk 5,11-DIHYDROBENZ[b,e][1,4]OXAZEPIN-DERIVATE UND DIESE ENTHALTENDE MEDIZINISCHE ZUBEREITUNGEN
PT915088E (pt) 1997-10-31 2003-01-31 Hoffmann La Roche Derivados de d-prolina
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
AU1708099A (en) 1998-06-03 1999-12-20 Amgen, Inc. N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
EP1475373A1 (en) * 1999-01-08 2004-11-10 Ajinomoto Co., Inc. 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists
EP1219611A4 (en) * 1999-09-03 2003-03-19 Ajinomoto Kk NEW PROCESSES FOR THE PRODUCTION OF OXAZEPINE DERIVATIVES
EP1403258A4 (en) 2001-05-30 2005-06-08 Ajinomoto Kk DIHYDRODIARY LOXAZEPINE DERIVATIVE AND A DERIVATIVE MEDICAL COMPOSITION
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
JP2005343791A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc 消化管疾患を治療するための医薬組成物
US20110034469A1 (en) 2009-08-04 2011-02-10 Takeda Pharmaceutical Company Limited Heterocyclic Compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB988008A (no) * 1900-01-01
GB774882A (en) * 1954-06-21 1957-05-15 Rhone Poulenc Sa Improvements in or relating to phenthiazine derivatives
GB975705A (en) * 1960-04-14 1964-11-18 Westminster Bank Ltd Improvements in or relating to the preparation of 3-alkylmercapto phenothiazines and intermediates formed in the process
CH407127A (de) * 1962-02-19 1966-02-15 Geigy Ag J R Verfahren zur Herstellung von N-heterocyclischen Verbindungen
US3188322A (en) * 1962-08-08 1965-06-08 Olin Mathieson Dihydrodibenzothiazepines

Also Published As

Publication number Publication date
IL94457A0 (en) 1991-06-10
HU903197D0 (en) 1990-10-28
NO902336L (no) 1990-11-28
HUT58329A (en) 1992-02-28
PT94151B (pt) 1996-12-31
DE69010285T2 (de) 1994-10-13
CA2017535A1 (en) 1990-11-27
CN1047673A (zh) 1990-12-12
ES2055867T3 (es) 1994-09-01
JPH057389B2 (no) 1993-01-28
EP0404359A1 (en) 1990-12-27
DE69010285D1 (de) 1994-08-04
AU5595490A (en) 1990-11-29
FI902632A0 (fi) 1990-05-25
IE64196B1 (en) 1995-07-12
FI96950C (fi) 1996-09-25
US5071844A (en) 1991-12-10
PT94151A (pt) 1991-01-08
CA2017535C (en) 2000-02-29
PL285350A1 (en) 1991-05-20
KR900018091A (ko) 1990-12-20
JPH0317079A (ja) 1991-01-25
DD294718A5 (de) 1991-10-10
ATE107927T1 (de) 1994-07-15
GB8912303D0 (en) 1989-07-12
FI96950B (fi) 1996-06-14
DK0404359T3 (da) 1994-07-25
IE901883L (en) 1990-11-27
EP0404359B1 (en) 1994-06-29

Similar Documents

Publication Publication Date Title
ES2088537T3 (es) Derivados de piranil cianoguanidina.
DK0791571T3 (da) Benzoylderivater
DK0850926T3 (da) Difluorprostaglandinderivater og deres anvendelse
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
NO902336L (no) Antispasmotiske midler.
DK0613894T3 (da) N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf
IL122123A0 (en) Atherosclerosis treatment
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
DK1109817T3 (da) Phosphohalogenhydriner, deres fremstilling og anvendelse
NZ260159A (en) N-bicyclic nitrogen compounds and medicaments
ATE243209T1 (de) Tetrahydro gamma-carboline
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
ATE184880T1 (de) Glukopyranosid-benzothiophene
DK0819687T3 (da) Benzothiophenforbindelser og anvendelser og formuleringer deraf
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FI904449A0 (fi) N-azasicyklo/3.3.0/oktanamider av aromatiska syror.
NO914192L (no) 8-azabicyklo(3.2.1)oktylalkylthiazolidinoner, fremgangsmaate for fremstilling og anvendelse som medikamenter
ATE71364T1 (de) Fluor enthaltende vitamin-d2-derivate.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.